Mackenzie Financial Corp Alkermes Plc. Transaction History
Mackenzie Financial Corp
- $63.2 Billion
- Q2 2024
A detailed history of Mackenzie Financial Corp transactions in Alkermes Plc. stock. As of the latest transaction made, Mackenzie Financial Corp holds 261,404 shares of ALKS stock, worth $7.1 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
261,404
Previous 267,712
2.36%
Holding current value
$7.1 Million
Previous $7.25 Million
13.07%
% of portfolio
0.01%
Previous 0.01%
Shares
19 transactions
Others Institutions Holding ALKS
# of Institutions
346Shares Held
183MCall Options Held
209KPut Options Held
89.4K-
Black Rock Inc. New York, NY29.1MShares$791 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA20MShares$543 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA14.4MShares$390 Million0.06% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD11MShares$299 Million0.03% of portfolio
-
State Street Corp Boston, MA9.22MShares$250 Million0.01% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $4.46B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...